Tickers

1. Composite Trajectory Verdict

For a pre-revenue SPAC with no operating business, the balance sheet and cash flow statement matter most because they track the depletion of working capital outside the trust account and the ability to fund operations until a business combination or liquidation; the income statement is driven almost entirely by non-operating trust interest income and non-recurring transaction costs.

Composite Trajectory: Deteriorating

The balance sheet shows a steadily worsening working capital deficit (from $706K at Dec 2021 to $3.19M at Mar 2023) and declining cash outside trust (from $611K to $143K over the same period) (10-K 2022, Consolidated Balance Sheets; 10-Q 2023-03-31, Consolidated Balance Sheets). Cash flow from operations remains negative in every period, with the quarterly burn accelerating from $9K in Q1 2022 to $109K in Q1 2023 (10-Q 2022-03-31, Condensed Statements of Cash Flows; 10-Q 2023-03-31, Condensed Statements of Cash Flows). The income statement shows a shift to net income in Q1 2023 ($1.22M) but only because trust interest income ($1.58M) exceeded G&A ($357K), not from operating performance (10-Q 2023-03-31, Condensed Statements of Operations). All three statements point to declining liquidity outside the trust.

2. Red Flags

• Cash outside trust fell from $610,926 (Dec 2021) to $142,759 (Mar 2023), a 77% decline, while accounts payable and accrued expenses rose from $706,224 to $3,368,733 (10-K 2022, Consolidated Balance Sheets; 10-Q 2023-03-31, Consolidated Balance Sheets).
• Working capital deficit widened each period: $706K (Dec 2021) → $2.25M (Sep 2022) → $2.83M (Dec 2022) → $3.19M (Mar 2023) (10-K 2022, MD&A; 10-Q 2022-09-30, MD&A; 10-Q 2023-03-31, MD&A).
• Accumulated deficit grew from $2.03M (Dec 2021) to $5.34M (Mar 2023) (10-K 2022, Consolidated Balance Sheets; 10-Q 2023-03-31, Consolidated Balance Sheets).
• Management explicitly states "substantial doubt" about ability to continue as a going concern in every quarterly filing since Q3 2022 (10-Q 2022-09-30, MD&A; 10-Q 2023-03-31, MD&A).
• Two shareholder demand letters alleging material nondisclosure in the business combination were received in January 2023 (10-K 2022, Litigation).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

FY2022 net loss ($837,116) was nearly identical to the inception-to-Dec-2021 loss ($841,299), but composition shifted: G&A rose from $846,086 to $2,951,973 while trust interest income jumped from $4,787 to $2,144,858 (10-K 2022, Consolidated Statements of Operations). Quarterly trends show Q1 2022 net loss of $824,761 (G&A $838,607, interest $13,846) versus Q1 2023 net income of $1,221,132 (G&A $357,226, interest $1,578,358) (10-Q 2023-03-31, Condensed Statements of Operations). The swing to income is entirely due to higher short-term rates on trust assets, not operating improvement; G&A remains the sole operating expense and fluctuates with transaction activity.

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Deteriorating

Operating cash outflows persisted in every period: $356,845 (inception-2021), $359,061 (FY2022), $300,118 (nine months ended Sep 2022), $9,246 (Q1 2022), and $109,106 (Q1 2023) (10-K 2022, Consolidated Statements of Cash Flows; 10-Q 2022-09-30, Condensed Statements of Cash Flows; 10-Q 2023-03-31, Condensed Statements of Cash Flows). Cash outside the trust declined monotonically from $610,926 (Dec 2021) to $310,808 (Sep 2022) to $251,865 (Dec 2022) to $142,759 (Mar 2023) (10-K 2022, Consolidated Balance Sheets; 10-Q 2022-09-30, Consolidated Balance Sheets; 10-Q 2023-03-31, Consolidated Balance Sheets). No financing or investing inflows have occurred since the 2021 IPO.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Deteriorating

Total current assets (cash + prepaids) fell from $758,253 (Dec 2021) to $181,218 (Mar 2023) while total current liabilities (accounts payable/accrued) rose from $706,224 to $3,368,733, driving the working capital deficit from -$706K to -$3.19M (10-K 2022, Consolidated Balance Sheets; 10-Q 2023-03-31, Consolidated Balance Sheets). The trust account grew from $146.63M to $150.32M solely from interest accrual (10-K 2022, Consolidated Balance Sheets; 10-Q 2023-03-31, Consolidated Balance Sheets). Class A shares subject to redemption increased from $143.75M to $147.45M, reflecting the same interest accretion (10-K 2022, Consolidated Balance Sheets; 10-Q 2023-03-31, Consolidated Balance Sheets). Stockholders' deficit deepened from -$2.03M to -$5.34M (10-K 2022, Consolidated Balance Sheets; 10-Q 2023-03-31, Consolidated Balance Sheets).

6. Data Gaps

• Standalone Q2 2022 and Q4 2022 income statements and cash flow statements (only YTD and FY figures available)
• Detailed breakdown of G&A expenses by category (legal, due diligence, audit, etc.) for each quarter
• Terms and draw schedule of any working capital loans from sponsor (filings state none outstanding as of each period end)
• Redemption activity on Class A shares (no redemptions reported through Mar 2023)
• Post-combination pro forma financials for Marti Technologies Inc. (target financials not included in these filings)